JUBLPHARMANSEJubilant Pharmova LimitedMinimalNeutral
Announced Thu, 19 Jun · 15:26 IST

Jubilant Pharmova Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hari Shanker Bhartia Family Trust, part of the promoter group of Jubilant Pharmova Limited, has filed a yearly compliance declaration with the stock exchanges and the company's audit committee. The filing confirms that none of the promoters or persons acting in concert have created any encumbrance (pledge, lien, or charge) on their shares in Jubilant Pharmova during the financial year ended March 31, 2025. The submission covers the entire promoter and promoter group, including the Bhartia family members, the family trusts, and various promoter-group holding entities such as Nikita Resources, Jubilant Enpro, VAM Holdings, and others.

Likely market impact

This is a routine annual compliance filing and is a positive signal for shareholders, as it confirms that no promoter shares are pledged. Lower pledged holdings reduce the risk of forced selling and indicate promoter confidence in the company.